Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ AI boom sparks Kingboard subsidiary′s US$1.5 billion stake sale to ramp up PCB capacity (SCMP) +++ KINGBOARD LAMINATES Aktie -3,54%

THERMO FISHER Aktie

 >THERMO FISHER Aktienkurs 
405.5 EUR    -0.4%    (TradegateBSX)
Ask: 405.5 EUR / 45 Stück
Bid: 402.5 EUR / 45 Stück
Tagesumsatz: 286 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>THERMO FISHER Performance
1 Woche: -4,3%
1 Monat: +8,6%
3 Monate: 0%
6 Monate: -15,3%
1 Jahr: +16,7%
laufendes Jahr: -17,1%
>THERMO FISHER Aktie
Name:  THERMO FISHER SCIENTIFIC
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US8835561023 / 857209
Symbol/ Ticker:  TN8 (Frankfurt) / TMO (NYSE)
Kürzel:  FRA:TN8, ETR:TN8, TN8:GR, NYSE:TMO
Index:  S&P500
Webseite:  https://www.thermofisher...
Profil:  Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, laboratory equipment, diagnostics consumables, and life science reagents. The company operates through four main segments: analytical technologies, which focuses on advanc..
>Volltext..
Marktkapitalisierung:  151597.2 Mio. EUR
Unternehmenswert:  186173.58 Mio. EUR
Umsatz:  38920.49 Mio. EUR
EBITDA:  9761.77 Mio. EUR
Nettogewinn:  5897.88 Mio. EUR
Gewinn je Aktie:  15.69 EUR
Schulden:  37167.23 Mio. EUR
Liquide Mittel:  2805.56 Mio. EUR
Operativer Cashflow:  7136.18 Mio. EUR
Bargeldquote:  0.22
Umsatzwachstum:  -1.35%
Gewinnwachstum:  -1.56%
Dividende je Aktie:  1.14 EUR
Dividendenrendite:  0.37%
Dividendenschätzung:  0.4%
Div. Historie:  13.03.26 - 0.409417€
15.12.25 - 0.365586€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  THERMO FISHER
Letzte Datenerhebung:  17.06.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 371.62 Mio. St.
Frei handelbar: 99.76%
Rückkaufquote: 2.27%
Mitarbeiter: 125000
Umsatz/Mitarb.: 0.31 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 26.88%
Bewertung:
KGV: 25.85
KGV lG: 18.98
KUV: 3.89
KBV: 3.36
PEG-Ratio: 3.85
EV/EBITDA: 19.07
Rentabilität:
Bruttomarge: 40.13%
Gewinnmarge: 15.15%
Operative Marge: 18.87%
Managementeffizenz:
Gesamtkaprendite: 6.45%
Eigenkaprendite: 13.52%
 >Anleihen 
>Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
12.06.26 - 00:01
XETR: DIVIDEND/INTEREST INFORMATION - 15.06.2026 - US8835561023 (XETRA)
 
Das Instrument TN8 US8835561023 THERMO FISH.SCIENTIF.DL 1 EQUITY wird cum Dividende/Zinsen gehandelt am 12.06.2026 und ex Dividende/Zinsen am 15.06.2026 The instrument TN8 US8835561023 THERMO FISH.SCIENTIF.DL 1 EQUITY has its pre-dividend/interest day on 12.06.2026 and its ex-dividend/interest day on 15.06.2026...
10.06.26 - 09:06
Polymer Factory Enters Material Transfer Agreement with Thermo Fisher Scientific (Cision)
 
Polymer Factory Sweden AB has entered into a Material Transfer Agreement (MTA) with Thermo Fisher Scientific, a global leader in analytical instruments, life sciences, and laboratory solutions. The agreement establishes a framework for evaluating materials and potential calibration products based on Polymer Factory's proprietary SpheriCal® technology platform. Under the agreement, the parties will explore selected product concepts and application areas within analytical instrumentation and mass spectrometry. SpheriCal® is Polymer Factory's patented dendritic polymer technology developed...
02.06.26 - 11:30
The Zacks Analyst Blog Highlights Microsoft, Dell, Thermo Fisher,Village Super Market and Comstock (Zacks)
 
MSFT is benefiting from AI momentum, Copilot adoption and accelerating Azure growth, even as capacity constraints persist....
02.06.26 - 00:15
Top Analyst Reports for Microsoft, Dell & Thermo Fisher (Zacks)
 
Microsoft, Dell and Thermo Fisher lead today's analyst picks as AI demand, cloud growth and biotech expansion shape outlooks and key risks....
29.05.26 - 19:00
Is Thermo Fisher Scientific Stock Underperforming the S&P 500? (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
29.05.26 - 17:00
Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains? (Zacks)
 
Thermo Fisher (TMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term....
21.05.26 - 07:15
Thermo Fisher Scientific declares $0.47 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.05.26 - 23:06
Thermo Fisher Scientific Announces Quarterly Dividend (Business Wire)
 
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems,...
19.05.26 - 12:42
Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG (PR Newswire)
 
NEWARK, Del., May 19, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights (FMI), the global Cell Culture Media Market is projected to grow from USD 3.7 billion in 2026 to USD 7.1 billion by 2036, expanding at a CAGR of 6.6% during the forecast period.......
18.05.26 - 12:30
Do Wall Street Analysts Like Thermo Fisher Scientific Stock? (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
13.05.26 - 22:09
Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer (PR Newswire)
 
Thermo Fisher Scientific, the world leader in serving science, will now manufacture drug product for Nuvation Bio in the United States Move by Nuvation Bio further ensures critical drug supply for patients and providers NEW YORK, May 13, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE:......
04.05.26 - 16:45
International Markets and Thermo Fisher (TMO): A Deep Dive for Investors (Zacks)
 
Examine Thermo Fisher's (TMO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock....
30.04.26 - 03:01
Insiderhandel: President & COO verkauft Aktien von Thermo Fisher Scientific im Wert von 185064 USD (Insiderkauf)
 
Pettiti, Gianluca - Vorstand - Tag der Transaktion: 2026-04-27...
27.04.26 - 16:12
Thermo Fisher to Sell Microbiology Business to Astorg (WSJ EN)
 
Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion....
27.04.26 - 16:06
Thermo Fisher to Sell Microbiology Business to Astorg (WSJ EN)
 
Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion....
27.04.26 - 15:18
Thermo Fisher to Sell Microbiology Business to Astorg (WSJ EN)
 
Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion....
27.04.26 - 14:37
Thermo Fisher To Sell Microbiology Business To Astorg (AFX)
 
WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO), on Monday, announced that it has signed a definitive agreement to sell its microbiology business to Astorg.The transaction is approximat......
27.04.26 - 14:31
Thermo Fisher to sell its microbiology business to Astorg for about $1.08 billion (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
27.04.26 - 14:12
Thermo Fisher to sell microbiology unit to Astorg for $1.08B (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Gegen alle Menschen äußerlich nie die Verachtung merken lassen, die sie verdienen, denn man kann nicht wissen, wo man sie braucht. - Ludwig van Beethoven
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!